51 related articles for article (PubMed ID: 20671072)
1. Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats.
Gelosa P; Banfi C; Gianella A; Brioschi M; Pignieri A; Nobili E; Castiglioni L; Cimino M; Tremoli E; Sironi L
J Pharmacol Exp Ther; 2010 Nov; 335(2):324-31. PubMed ID: 20671072
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of AMPK/PPARα/UCP2 axis in relation to hypertension and aging in the brain, kidneys and heart of two closely related spontaneously hypertensive rat strains.
Rubattu S; Bianchi F; Busceti CL; Cotugno M; Stanzione R; Marchitti S; Di Castro S; Madonna M; Nicoletti F; Volpe M
Oncotarget; 2015 Aug; 6(22):18800-18. PubMed ID: 26023797
[TBL] [Abstract][Full Text] [Related]
3. The PPARα Agonist Fenofibrate Prevents Formation of Protein Aggregates (Mallory-Denk bodies) in a Murine Model of Steatohepatitis-like Hepatotoxicity.
Nikam A; Patankar JV; Somlapura M; Lahiri P; Sachdev V; Kratky D; Denk H; Zatloukal K; Abuja PM
Sci Rep; 2018 Aug; 8(1):12964. PubMed ID: 30154499
[TBL] [Abstract][Full Text] [Related]
4. High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway.
Chung HW; Lim JH; Kim MY; Shin SJ; Chung S; Choi BS; Kim HW; Kim YS; Park CW; Chang YS
Nephrol Dial Transplant; 2012 Jun; 27(6):2213-25. PubMed ID: 22076434
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis.
Tanaka Y; Kume S; Araki S; Isshiki K; Chin-Kanasaki M; Sakaguchi M; Sugimoto T; Koya D; Haneda M; Kashiwagi A; Maegawa H; Uzu T
Kidney Int; 2011 Apr; 79(8):871-82. PubMed ID: 21270762
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory role of fenofibrate in treating diseases.
Jin L; Hua H; Ji Y; Jia Z; Peng M; Huang S
Biomol Biomed; 2023 May; 23(3):376-391. PubMed ID: 36724021
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling Protein 2 as a Pathogenic Determinant and Therapeutic Target in Cardiovascular and Metabolic Diseases.
Stanzione R; Forte M; Cotugno M; Bianchi F; Marchitti S; Busceti CL; Fornai F; Rubattu S
Curr Neuropharmacol; 2022; 20(4):662-674. PubMed ID: 33882809
[TBL] [Abstract][Full Text] [Related]
8. Anti-Inflammatory, Antioxidant, and Antifibrotic Effects of Kefir Peptides on Salt-Induced Renal Vascular Damage and Dysfunction in Aged Stroke-Prone Spontaneously Hypertensive Rats.
Chen YH; Chen HL; Fan HC; Tung YT; Kuo CW; Tu MY; Chen CM
Antioxidants (Basel); 2020 Aug; 9(9):. PubMed ID: 32858955
[TBL] [Abstract][Full Text] [Related]
9. Bilirubin, a Cardiometabolic Signaling Molecule.
Hinds TD; Stec DE
Hypertension; 2018 Oct; 72(4):788-795. PubMed ID: 30354722
[No Abstract] [Full Text] [Related]
10. The Microvascular and Macrovascular Benefits of Fibrates in Diabetes and the Metabolic Syndrome: A review.
Malur P; Menezes A; DiNicolantonio JJ; O'Keefe JH; Lavie CJ
Mo Med; 2017; 114(6):464-471. PubMed ID: 30228666
[TBL] [Abstract][Full Text] [Related]
11. Captopril alleviates hypertension-induced renal damage, inflammation, and NF-κB activation.
Gan Z; Huang D; Jiang J; Li Y; Li H; Ke Y
Braz J Med Biol Res; 2018 Sep; 51(11):e7338. PubMed ID: 30183974
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues.
Gallelli CA; Calcagnini S; Romano A; Koczwara JB; de Ceglia M; Dante D; Villani R; Giudetti AM; Cassano T; Gaetani S
Antioxidants (Basel); 2018 Jul; 7(7):. PubMed ID: 30021985
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling Protein 2: A Key Player and a Potential Therapeutic Target in Vascular Diseases.
Pierelli G; Stanzione R; Forte M; Migliarino S; Perelli M; Volpe M; Rubattu S
Oxid Med Cell Longev; 2017; 2017():7348372. PubMed ID: 29163755
[TBL] [Abstract][Full Text] [Related]
14. Reduced brain UCP2 expression mediated by microRNA-503 contributes to increased stroke susceptibility in the high-salt fed stroke-prone spontaneously hypertensive rat.
Rubattu S; Stanzione R; Bianchi F; Cotugno M; Forte M; Della Ragione F; Fioriniello S; D'Esposito M; Marchitti S; Madonna M; Baima S; Morelli G; Sciarretta S; Sironi L; Gelosa P; Volpe M
Cell Death Dis; 2017 Jun; 8(6):e2891. PubMed ID: 28640254
[TBL] [Abstract][Full Text] [Related]
15. Multifaceted Mechanisms of WY-14643 to Stabilize the Blood-Brain Barrier in a Model of Traumatic Brain Injury.
Neuhaus W; Krämer T; Neuhoff A; Gölz C; Thal SC; Förster CY
Front Mol Neurosci; 2017; 10():149. PubMed ID: 28603485
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial Dysfunction Contributes to Hypertensive Target Organ Damage: Lessons from an Animal Model of Human Disease.
Rubattu S; Stanzione R; Volpe M
Oxid Med Cell Longev; 2016; 2016():1067801. PubMed ID: 27594970
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease.
Granata S; Dalla Gassa A; Bellin G; Lupo A; Zaza G
Biomed Res Int; 2016; 2016():9290857. PubMed ID: 27419142
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Inflammatory Cytokines in Antiarrhythmic Effects of Clofibrate in Ouabain-Induced Arrhythmia in Isolated Rat Atria.
Moradi S; Nikoui V; Imran Khan M; Amiri S; Jazaeri F; Bakhtiarian A
Adv Pharmacol Sci; 2016; 2016():9128018. PubMed ID: 26977143
[TBL] [Abstract][Full Text] [Related]
19. PPARs Link Early Life Nutritional Insults to Later Programmed Hypertension and Metabolic Syndrome.
Tain YL; Hsu CN; Chan JY
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712739
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological manipulation of arachidonic acid-epoxygenase results in divergent effects on renal damage.
Li J; Stier CT; Chander PN; Manthati VL; Falck JR; Carroll MA
Front Pharmacol; 2014; 5():187. PubMed ID: 25177296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
